Search PDMR transactions

Notifier
Name of person with notification obligation
Francois-Regis Martelet
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Francois-Regis Martelet
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oasmia Pharmaceutical AB
Issuer´s LEI code
5493003TZPR4B7QO9L49
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
BTA Oasmia Pharmaceutical AB BTA SE0017564958 Subscription 12,200 Quantity 1.68 SEK 22/03/2022 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oasmia Pharmaceutical AB BTA SE0017564958 Subscription 22/03/2022 NASDAQ STOCKHOLM AB 12,200 (Quantity) 1.68 SEK
Total: 12,200
<< Back